NABL + USFDA Accredited

Pharmaceutical Testing Laboratory in Delhi | NABL & USFDA Accredited

Auriga Research's flagship Delhi facility provides NABL and USFDA-accredited pharmaceutical testing services. With a 950+ member scientific team and advanced instrumentation including HPLC, LCMS/MS, GC-MS, and ICP-MS, the Kirti Nagar laboratory handles the full spectrum of pharma QC and analytical needs.

Request a Quote Call +91- 7428116100

Lab Address

4/9 Kirti Nagar Industrial Area, New Delhi 110015

Hours: Mon-Sat, 9AM-5PM IST

Phone: +91 7428116100

Email: info@aurigaresearch.com

NABL USFDA WHO

View on Google Maps →

Pharmaceutical Testing Services

GMP-compliant pharmaceutical quality control and analytical services for APIs, formulations, and packaging materials.

Assay & Impurity Profiling

HPLC and GC-based assay determination, related substances, degradation impurities, and residual solvents per ICH guidelines.

Dissolution Studies

USP apparatus I-IV dissolution testing, dissolution profiling, and in-vitro release studies for solid and semi-solid dosage forms.

Stability Testing

ICH-compliant accelerated (40°C/75% RH), intermediate, and long-term stability studies with photostability testing.

Microbiological Testing

Microbial limit testing, sterility testing, bacterial endotoxin testing, and environmental monitoring per USP/IP.

Raw Material Testing

API identity, purity, and quality testing. Excipient testing per pharmacopoeial monographs (IP, USP, EP, BP).

Method Development & Validation

Analytical method development and ICH Q2(R1) validation for novel formulations, combination products, and biosimilars.

Pharmaceutical Testing in Delhi

Delhi NCR is home to hundreds of pharmaceutical manufacturers, importers, and distributors. As India's regulatory capital, proximity to CDSCO and the Central Drugs Laboratory makes Delhi the preferred testing location for regulatory submissions, product approvals, and compliance documentation.

Our Kirti Nagar facility handles the complete range of pharmacopoeial testing per IP, USP, EP, and BP monographs. The laboratory supports both routine batch release QC and complex analytical challenges including method development for novel drug delivery systems, combination products, and biosimilars. USFDA accreditation enables direct acceptance of test reports for US market filings.

For the complete scope of pharmaceutical testing services, visit our national pharmaceutical testing service page. For accreditation details, see our NABL accreditation page.